This module addresses characteristic issues influencing the registration of medicinal products based on monoclonal antibodies (mAbs), for use in humans. Regulatory requirements for the registration of biological medicinal products such as those based on mAbs differ in certain respects from those for small-molecule products. This is because of the distinct characteristics of biologics, such as complex structure and susceptibility to variation during manufacture.
Discover Energy Edge's course on decarbonising maritime propulsion. Enhance your knowledge with our virtual instructor-led training for sustainable maritime solutions.
Learn about CO2 sequestration and enhanced oil recovery in our EnergyEdge course. Gain valuable insights and practical knowledge. Enroll now.